Recent studies have demonstrated the impairment of cholesterol efflux mediation by ATP-binding cassette transporter A1 (ABCA1) and ATP-binding cassette transporter G1 (ABCG1) in the brains of individuals afflicted with AD [36]. The gene discussed is ABCA1; the disease is Alzheimer disease.